Skip to main content
. Author manuscript; available in PMC: 2010 Jun 18.
Published in final edited form as: Clin Cancer Res. 2009 May 26;15(11):3654–3662. doi: 10.1158/1078-0432.CCR-08-3293

Fig. 1.

Fig. 1

Expression of cyclin B1 in distinct subtypes and grade groupings of 390 human breast tumors (cohort A; BD) and 53 breast cancer cell lines (A). Cyclin B1 was quantified using RPPA and the quantification data were log 2 transformed and mean centered for expression on the Y axis. HER, HER2–positive; HR, hormone receptor–positive; TN, triple-negative.